sun pharma
Sun Pharma tumbles on report of fresh allegations by whistleblower
A whistleblower had approached SEBI late last year with a document alleging various irregularities by Sun Pharma.
China warms up to Indian pharma firms
Swift regulatory approvals in China would allow Indian companies to boost its revenue
Sensex tanks 113 points on 3-year high trade deficit, gloomy earnings
Trade deficit widened to almost a 3-year high of USD 14 billion last month as imports surged.
Sun Pharma receives USFDA nod for anti-cholesterol drug
The stock of Sun Pharmaceutical Industries was trading at Rs 539.50 on the BSE, up 1.19 per cent.
Sun Pharma shares hit 52-week low, tank over 13 pc
Sun Pharma on Friday reported a 14 per cent decline in consolidated net profit at Rs 1,223 crore for the fourth quarter.
Sun Pharma Q4 dips 14 per cent to Rs 1,223 cr
Sun Pharma shares today ended 3.93 per cent down at Rs 568.55 on the BSE.
Sun Pharma shares down 3 pc; m-cap dips by Rs 5,004 cr
Company's market capitalisation or m-cap tumbled Rs 5,004.17 crore to Rs 1,59,704.83 crore.
Taro to acquire Canada's Thallion Pharmaceuticals
Sun Pharmaceutical's indirect arm to buy the company for 2.7 million Canadian dollar.
Sun Pharma Q3 net profit slips 5 pc to Rs 1,471 cr
Shares of Sun Pharmaceutical Industries were trading at Rs 654.55 per scrip on BSE.
Sun Pharma Halol plant in trouble for quality control
The violations listed by the FDA after its latest inspection include problems with Sun's quality control system.